- Home
- CLST vs ECOR Comparison
CLST vs ECOR Comparison
Compare CLST & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- ECOR
- Stock Information
- Founded
- CLST 1922
- ECOR 2005
- Country
- CLST United States
- ECOR United States
- Employees
- CLST N/A
- ECOR N/A
- Industry
- CLST
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CLST
- ECOR Health Care
- Exchange
- CLST Nasdaq
- ECOR Nasdaq
- Market Cap
- CLST 48.8M
- ECOR 50.1M
- IPO Year
- CLST N/A
- ECOR 2018
- Fundamental
- Price
- CLST $12.00
- ECOR $5.00
- Analyst Decision
- CLST
- ECOR Strong Buy
- Analyst Count
- CLST 0
- ECOR 2
- Target Price
- CLST N/A
- ECOR $25.50
- AVG Volume (30 Days)
- CLST 5.1K
- ECOR 182.1K
- Earning Date
- CLST 04-24-2025
- ECOR 05-07-2025
- Dividend Yield
- CLST N/A
- ECOR N/A
- EPS Growth
- CLST N/A
- ECOR N/A
- EPS
- CLST 0.57
- ECOR N/A
- Revenue
- CLST $11,257,000.00
- ECOR $26,458,000.00
- Revenue This Year
- CLST N/A
- ECOR $26.76
- Revenue Next Year
- CLST N/A
- ECOR $44.87
- P/E Ratio
- CLST $21.12
- ECOR N/A
- Revenue Growth
- CLST 200.91
- ECOR 41.54
- 52 Week Low
- CLST $10.67
- ECOR $4.47
- 52 Week High
- CLST $12.40
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- CLST 62.86
- ECOR 38.81
- Support Level
- CLST $11.62
- ECOR $4.86
- Resistance Level
- CLST $12.00
- ECOR $5.49
- Average True Range (ATR)
- CLST 0.14
- ECOR 0.47
- MACD
- CLST 0.02
- ECOR 0.07
- Stochastic Oscillator
- CLST 50.00
- ECOR 38.08
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.